May 6th, 2015
•Here, we present a protocol to generate a proof-of-principle divalent adenovirus type 5 (Ad5) vector Ad5/H5-HVR1-KWAS-HVR5-His6 by utilizing the Antigen Capsid-Incorporation strategy. This vector was demonstrated to exhibit qualitative fitness, the capability to escape Ad5-positive sera in vitro, and the antigenicity as well as immunogenicity to the incorporated antigens.
Vídeos Relacionados
Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
Imaging CD4 T Cell Interstitial Migration in the Inflamed Dermis
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados